Abstract
This chapter provides an overview of nanoemulsions, elucidating their properties and their use in dermal drug delivery. The adaptation of these submicron-sized emulsion systems for different tasks of topical application is presented, and promising prospects as well as limitations are discussed. Nanoemulsions are generally aimed at targeting the outermost skin layers. Thus, recent findings of interest are presented, highlighting how modification of formulation parameters such as droplet size and surface charge or addition of specific surfactants, oil types and penetration enhancers can affect drug delivery. In addition to the high skin friendliness and physical stability of nanoemulsions, enhanced in vivo efficacy of drugs has been reported due to the specific morphology and composition of these systems. Since both lipophilic and hydrophilic actives can be incorporated, nanoemulsions represent vehicles of particular interest for dermal and cosmetic applications. Future research dealing with the biological effects of such systems in vivo is being anticipated with great interest.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
1.1 Definition and Characterisation of Nanoemulsions
Classical emulsions are dispersions of a liquid phase in another immiscible liquid phase. They have been employed for the dermal application of active substances for a long time since they can easily be produced through mild energy input and can be kinetically stabilised with the help of suitable surfactants.
During the last decades, technological and methodological progress has led to the development of oil-in-water emulsions with increasingly small droplet sizes. The first systems known as submicron emulsions emerged during the 1950s and were originally employed for parenteral nutrition (Wabel 1998; Calder et al. 2010). They were composed of natural oils such as soybean oil dispersed within an aqueous phase with the help of natural lecithin mixtures. The average droplet sizes of these systems produced through high-energy emulsification usually ranged between 100 and 500 nm. During the next decades, different high-energy production methods were established, including homogenisation with high-pressure homogenisers or microfluidisers as well as ultrasonication. Depending on the production technique and the employed compounds, droplet sizes around 100 nm could be reached, and the prevailing terminology changed from submicron emulsions to nanoemulsions.
Nanoemulsions of the oil-in-water type have been adapted for various routes of drug delivery, including sensitive routes such as intravenous, ocular or dermal application (Benita and Levy 1993; Yang and Benita 2000; Klang and Valenta 2011) while water-in-oil nanoemulsions have been investigated for technical applications as well as for theoretical surfactant studies (Chiesa et al. 2008; Porras et al. 2004). In addition to classical lecithin-based nanoemulsions produced by high-energy emulsification, new low-energy production methods have been developed, such as the phase inversion temperature method or the solvent evaporation method (Fernandez et al. 2004; Tadros et al. 2004; Sole et al. 2010). These methods require the use of specific surfactants or additional solvents to produce nano-sized oil droplets from a microemulsion matrix due to changes in the spontaneous surfactant curvature. Conveniently, these methods can be conducted rapidly without the need for specific equipment but may involve strong heating of the pre-emulsion system. Discussions about the exact nature of the produced systems are still ongoing. Important parameters such as mean droplet size and droplet size distribution again depend strongly on the employed compounds and exact processing conditions. Progress in the field of nanoemulsion production is constantly being reported for both high- and low-energy emulsification methods (Cortés-Muñoz et al. 2009; Anton et al. 2007).
In summary, the term nanoemulsion is employed to describe conventional emulsions with droplet sizes in the lower submicron range. It should be noted that droplet sizes of classical nanoemulsions, i.e. nanoemulsions stabilised by lecithin-type surfactants that are produced through high-energy emulsification, rarely reach mean droplet sizes below 100 nm. The general recommendation of accepted guidelines today is that the prefix nano is to be employed for systems with size ranges between 1 and 100 nm (Mason et al. 2006). Accordingly, the term nanoemulsion would only be appropriate for submicron emulsions with droplet sizes below 100 nm. However, the term nanoemulsion is widely – albeit inaccurately – employed as a synonym for the term submicron emulsion today. We would like to point out this slight discrepancy from nanoscale conventions: nanoemulsions do not necessarily exhibit droplet sizes below 100 nm.
To further complicate the terminology issue, increasing numbers of publications about ‘nanoemulsions’ are in fact dealing with microemulsions. As well known, microemulsions are thermodynamically stable isotropic systems that contain large amounts of surfactants and solvents and form spontaneously. Microemulsions may exhibit complex internal structures including bicontinuous sponge phases or droplet-shaped phases. Nevertheless, they bear no similarities to real emulsions such as nanoemulsions; the well-established term microemulsion is of historical nature. Several groups have taken up the task of clarifying these terminology issues that render literature research increasingly difficult (Klang and Valenta 2011; Mason et al. 2006; Anton and Vandamme 2011; McClements 2012).
To avoid confusion, we adhere to the nowadays established term nanoemulsion for emulsions with droplets in the lower submicron range. The majority of publications are dealing with oil-in-water nanoemulsions since they are more relevant for most applications than water-in-oil systems. Recent developments include adaptations such as multiple nanoemulsions for the delivery of drugs of different logP values (Anton et al. 2010; Schwarz et al. 2012).
With decreasing droplet size, the general properties of nanoemulsions start to differ significantly from those of conventional emulsions. Although nanoemulsions exhibit basic emulsion properties such as an inherent metastability, they differ from macroscale emulsions in regard to optical appearance, physicochemical properties and prevailing destabilisation processes (Klang and Valenta 2011; Mason et al. 2006). Nanoemulsions may exhibit a transparent to translucent appearance if the droplet size is small enough while emulsions are generally creamy white due to multiple scattering of light. In addition, nanoemulsions are of a fluid nature and exhibit near-Newtonian flow behaviour, while classical emulsions are usually of higher viscosity and shear-thinning flow behaviour. Most importantly, nanoemulsions may exhibit significantly improved physical stability during storage when compared to conventional emulsions. Classical emulsions are sooner or later destabilised by gravity-induced alterations, coalescence of oil droplets and eventual phase separation. Nanoemulsions are hardly affected by coalescence due to their small droplet size. If the dispersed droplets have a relatively high solubility within the continuous phase, Ostwald ripening may occur: individual molecules of the dispersed phase diffuse from smaller to larger droplets due to differences in Laplace pressure, thus leading to a continuous increase in droplet size. By considerate choice of excipients, however, this destabilisation mechanism occurring in nanoemulsions may be largely eliminated (Wabel 1998; Mason et al. 2006). Enhanced electrochemical stabilisation through modification of the droplet surface charge and sterical stabilisation with spacious surface-active agents are successful strategies to further optimise nanoemulsion stability (van Nieuwenhuyzen and Szuhaj 1998).
Characterisation of the above-mentioned properties of nanoemulsions can usually be performed by common analytical techniques for aqueous colloidal systems. Dynamic light scattering as a population-based technique of droplet size characterisation is frequently employed, ideally in combination with static laser diffraction to exclude the presence of individual large droplets. In addition, microscopic techniques such as cryo-transmission electron microscopy are recommended to obtain information about the exact morphology of the system including droplet shape and the presence of vesicular structures (Klang et al. 2012a). Examples of different techniques of analysis including electron microscopy and atomic force microscopy are presented in Fig. 18.1.
Apart from analysing droplet size distributions, the droplet surface charge as an indicator for electrochemical stabilisation can be determined by laser Doppler electrophoresis (Mueller 1996). Stability investigations are usually performed by monitoring parameters such as the mean droplet size, the polydispersity index, droplet surface charge and pH value of the nanoemulsions in question. In our experience, the physical stability of classical nanoemulsions produced by high-pressure homogenisation can be expected to be around 2 years or longer at slightly refrigerated storage. However, the chemical stability of individual compounds has to be taken into account as well. Oil, surfactants and incorporated actives may be subjected to chemical degradation by oxidation or hydrolysis, potentially leading to an unpleasant optical and olfactory appearance despite unchanged droplet size (Wabel 1998; Baker and Naguib 2005). Optical monitoring of the formulations, assessment of drug stability and monitoring of both zeta potential and pH are useful tools in detecting such changes (Klang et al. 2011a).
1.2 Dermal Application: Advantages and Limitations
Most marketed nanoemulsion products can be found in the realms of intravenous nutrition and drug delivery as well as in dermal drug delivery and cosmetics. In terms of dermal drug delivery, nanoemulsions offer distinct advantages: high physical stability compared to conventional emulsions, high skin friendliness due to the low amount and the mild nature of the employed surfactants and last but not least the ease of preparation and scale-up. They avoid the limitations of other colloidal drug delivery systems, such as the limited drug loading and stability issues of liposomes and the potentially irritating compounds required for the production of nanoparticles or microemulsions. Depending on composition and the nature of the employed drug, nanoemulsions may achieve higher rates of skin penetration and drug accumulation within the skin than lipid nanoparticles (Calderilla-Fajardo et al. 2006). In a recent study investigating the dermal delivery of lutein, a more rapid release in case of nanoemulsions was found, which achieved higher skin permeation rates than nano-structured lipid carriers and solid lipid nanoparticles (Mitri et al. 2011).
Classical nanoemulsions prepared by high-pressure homogenisation are usually stabilised by skin-friendly surfactants such as lecithins and do not require synthetic surfactants. Thus, skin lipids are not washed out during cleaning. Lipophilic drugs can be incorporated into the oil phase according to their solubility. The release of the drugs from the system is generally acknowledged to be quite rapid; however, attempts towards retarded or controlled release as well as site-specific targeting have been reported as well (Yang and Benita 2000; Eskandar et al. 2009). Nanoemulsions support the penetration of incorporated actives into the skin and may thus promote their accumulation in the skin. In addition, the cosmetic effect of the basic vehicles is of further interest. In recent approaches, the possibility to incorporate hydrophilic drugs into nanoemulsion systems is being investigated with the aim of promoting the incorporation efficiency, stability and penetration of water-soluble actives (Anton et al. 2010; Schwarz et al. 2012).
Retarded drug delivery from nanoemulsions is difficult to achieve because of the low viscosity of the systems. When compared to aqueous solutions or dispersions, retarded drug release from nanoemulsions may of course be observed. In general, a retarded release may be achieved for very lipophilic drugs with high affinity to the oil phase.
From another viewpoint, the low viscosity of nanoemulsions is an advantageous feature: it renders them attractive systems for development of aerosol sprays such as sunscreens that show no phase separation during storage. If a higher viscosity is required, modification of the nanoemulsion is possible by incorporation of gelling agents. Successful reports on the development of thickened nanoemulsions can be found in the literature (Alves et al. 2005; Mou et al. 2008).
Regarding transdermal penetration, there is a certain amount of recent literature proposing nanoemulsions for this task. However, a closer look at these articles reveals that the systems in question are exclusively dealing with thermodynamically stable microemulsion phases. Nanoemulsions in the sense of skin-friendly submicron-sized emulsion systems are not specifically designed for the purpose of delivering drugs transdermally. To allow for the passage of intact nanovectors across pores of the skin, much smaller and deformable carriers are required since the skin is a strong and complex barrier (Cevc and Vierl 2010). Small drug amounts may of course be found in deeper skin layers after application of a nanoemulsion system due to mechanisms such as penetration across hair follicles (Lademann et al. 2001) or a general penetration enhancement caused by the involved excipients, in particular the involved lecithin phospholipids (Yu et al. 2009). In general, however, nanoemulsions are not employed for transdermal drug delivery, but rather for targeting the outermost skin layers, for instance, in case of fungal infections or inflammation. The versatile nature of nanoemulsions is highlighted by another recent study by Spagnul et al., who designed a calixarene nanoemulsion aimed at chelating uranium molecules at the skin surface (Spagnul et al. 2011). The patented formulation is a promising approach towards treating cutaneous uranium contamination if the formulation is applied quickly. This study shows that nanoemulsions exhibit advantageous properties for different applications on skin and can be tailor-made according to the envisioned task.
In another recent study, a lecithin-based nanoemulsion containing 5-aminolevulinic acid (5-ALA) was developed for dermal application in photodynamic therapy (Maisch et al. 2010). Significantly deeper skin penetration was found for the nanoemulsion when compared to a conventional creamy emulsion (Fig. 18.2). As intended in localised therapy, no penetration beyond the basal cell membrane was observed. The increased drug transport into the epidermis may be ascribed to a stabilising effect of the nanoemulsion on 5-ALA, thus preventing dimerisation. Furthermore, the nanoemulsion formulation seemed to support the cellular uptake of 5-ALA. Recently, the pivotal phase III studies were completed for the developed system. The results support the claims of improved stability and skin penetration when tested against a conventional cream and placebo (Dirschka et al. 2012). The corresponding product has successfully been marketed (Ameluz®, Biofrontera Pharma GmbH).
Regarding the mechanism of nanoemulsion penetration, it can be summarised that no evidence exists that conventional colloidal systems such as nanoemulsions may penetrate into the skin as intact structures. It may thus be assumed that their skin penetration is related to penetration of the system into shunt pathways such as hair follicles, accumulation of the system between corneocyte clusters or in furrows to interact with skin lipids or merging of the system into extended lipidic structures on the skin surface. In this context, penetration enhancement of drugs may be caused by the occlusion of the skin surface (Eskandar et al. 2009; Zhou et al. 2010) as well as the interaction of nanoemulsion excipients such as phospholipids with skin compounds. The systems may alter the thermodynamic activity of incorporated drugs on the skin surface as well (Cevc and Vierl 2010). According to their composition, nanoemulsions may thus be employed to enhance the penetration of incorporated actives into the skin. Different aspects may influence the success of this strategy, such as the exact formulation morphology, the droplet surface charge and the nature of the involved compounds. The role of these factors will be discussed in the following sections.
2 Penetration Enhancement Strategies
2.1 Role of Droplet Size
The large surface area and low surface tension of small nanoemulsion oil droplets has been described to improve skin interaction and thus dermal drug delivery (Benita 1999; Klang et al. 1998). An enhanced local therapeutic effect of incorporated drugs due to prolonged residence time in the uppermost skin layers may thus be expected. One of the earliest studies dealing with the effect of nanoscale droplet size in topical emulsions was conducted by Friedman et al. (1995). Both steroidal and nonsteroidal antiinflammatory drugs including betamethasone valerate and dipropionate, naproxen, diclofenac, indomethacin and piroxicam were incorporated into nanoemulsions and regular creamy emulsions of identical composition. The antiinflammatory efficacy of the systems was compared against each other and to established marketed formulations by using the carrageenan-induced paw edema rat model. Significantly improved antiinflammatory efficacy was found for the nanoemulsion systems, especially in case of indomethacin, diclofenac and betamethasone esters. Noticeable systemic activity of antiinflammatory drugs formulated in nanoemulsions was observed as well. Preliminary in vivo studies on human volunteers showed good acceptability and comparable properties to marketed products. The authors hypothesised that lipid disruption within the stratum corneum caused by the nanoemulsion phospholipids, the formation of gaps and the increased swelling of the skin may favour the penetration of lipid droplets with diameters below 100 nm. Under these circumstances, shunt pathways such as hair follicles or sebaceous channels may lead to enhanced penetration as well. It should be kept in mind, however, that these conditions may be particularly encountered in the employed edema model. In a more recent study, Kotyla and co-workers compared the bioavailability of tocopherol from a nanoemulsion and a micrometre-sized emulsion of the same composition. After dermal application of the nanoemulsion in vivo on golden hamster skin, a 2.5-fold increase in plasma tocopherol levels was determined (Kotyla et al. 2008).
These studies held aside, literature about the role of droplet size on the skin penetration of otherwise identical emulsions is scarce. However, by experimenting with certain sucrose ester surfactants with peculiar gelling behaviour, we were able to create both fluid nanoemulsions and semisolid emulsions of identical composition. When evaluating the skin penetration potential of these systems in vitro (Klang et al. 2011b) and in vivo (Klang et al. 2012b), we found a highly similar penetration behaviour irrespective of the respective droplet size distribution. This may however be related to the specific nature of the developed emulsions, in particular the hydrophilic gel network of the semisolid emulsions. For aqueous dispersions based on the same network, the microviscosity and thus the drug transport were found to be comparable to that of corresponding fluid nano-sized systems (Ullrich et al. 2008). For the developed sucrose stearate emulsions, droplet sizes around 120–150 nm did not significantly affect the skin penetration of incorporated drugs when compared to corresponding emulsions with droplet sizes in the micrometre range. Further comparative studies in this direction using nanoemulsions with droplet sizes below 100 nm would be of interest to gain further information on this matter.
In another recent study, lecithin nanoemulsions for topical delivery were developed using snake oil, soybean lecithin, glycerol and purified water (Zhou et al. 2010). When applied in an O/W cream, the nano-sized droplets were shown to enhance skin hydration and skin penetration of the incorporated model dye nile red into the dermis when compared to a control O/W cream. The authors observed increased skin adhesion of the nanoemulsion formulation to the skin surface and subsequent formation of an occlusive film, thus increasing skin hydration and consequently skin penetration of the model dye. The increased skin penetration can therefore be ascribed to physical effects caused by the presence of small oil droplets. In addition, the authors assumed that an increased partitioning of lecithin molecules into the stratum corneum might be responsible for subsequent changes in the barrier properties, i.e. that the observed effects could be ascribed to the employed nanoemulsion compounds.
Another study reported increased in vitro skin permeation rates of camphor, menthol and methyl salicylate through rat skin when the substances were applied in form of a hydrogel-thickened nanoemulsion instead of a control gel (Mou et al. 2008). The authors speculated that different factors, e.g. high concentration gradients, formation of drug reservoirs or embedding of the small oil droplets within the stratum corneum lipids, might account for the observed enhancement effect.
In another recent study, penetration enhancement of glycyrrhetic acid incorporated into a nanoemulsion was observed in vitro when compared to a conventional oil-in-water emulsion of different composition (Puglia et al. 2010). In addition, an increased antiinflammatory activity in vivo was observed for the nanoemulsion. However, the authors stated that the nature of the employed excipients for the different nanoemulsion and emulsion systems may have influenced the obtained results. This again confirms that the beneficial effects obtained with nanoemulsion depend not only on the droplet size but on the nature of the developed systems as well as the employed compounds.
2.2 Role of Droplet Surface Charge
The surface charge of nanoemulsion oil droplets in dispersion, often described by the zeta potential, is an important aspect that may strongly affect the interaction between formulation and skin and drug penetration. A positive droplet surface charge has been observed to enhance penetration of drugs into the nasal and ocular mucosae as well as the stratum corneum of the skin (Yang and Benita 2000; Mou et al. 2008). A high absolute surface charge of the nanoemulsion droplets is also a crucial prerequisite to ensure physical stability upon storage. From this viewpoint, a high positive surface charge may fulfil both the tasks of enhancing stability and promoting skin penetration.
A positive zeta potential can be induced by using cationic excipients such as lipids, polymers and surfactants, which can result in an improved interaction with negatively charged membranes such as the skin or corneal membrane. Negatively charged protein or fatty acid residues of the skin as well as the presence of selective active ion pumps render the skin surface selective to positively charged substances (Yang and Benita 2000; Piemi et al. 1999). It has been established by Benita and co-workers that positively charged nanoemulsions exhibited better wettability on the cornea compared to saline or negatively charged systems (Yang and Benita 2000). In dermal drug delivery, the same strategy was followed in several studies. Piemi et al. found that the in vitro penetration of econazole and miconazole nitrate into rat skin was higher from positively charged nanoemulsions containing stearylamine than from negatively charged formulations containing deoxycholic acid (Piemi et al. 1999). The binding of surfactants to the skin can be attributed to non-specific hydrophobic interactions with keratin as well as to specific electrostatic interactions in case of charged surfactants; the latter phenomenon is strongly dependent on the pH of formulation and skin. The obtained results suggest that the surface charge of nanoemulsion droplets may affect skin penetration of drugs due to increased interaction with the target site. Similar results were reported in subsequent studies for stearylamine (Fang et al. 2004) and phytosphingosine (Hoeller et al. 2009; Klang et al. 2010), although the observed enhancement effects were not as pronounced in case of the latter. Baspinar and co-workers likewise employed phytosphingosine to produce a positively charged nanoemulsion for dermal application of prednicarbate. Higher drug release was observed for negatively charged nanoemulsions in vitro when using diffusion cells and a synthetic model membrane. However, significantly higher amounts of the active ingredient were found to penetrate into the skin from the positively charged nanoemulsion when using excised human skin (Baspinar and Borchert 2012). These results suggest that a positive surface charge in nanoemulsions may indeed be of value for in vivo skin penetration.
2.3 Role of Compounds
2.3.1 Role of Surfactant Type
A wide range of permeation enhancers are known to promote drug penetration into the skin or mucous membranes. Classical nanoemulsion surfactants such as phospholipids and lysophospholipids act by interfering with the structure of skin lipids, thereby enhancing the transport of co-applied substances into the skin (Kirjavainen et al. 1999). Current research focuses on identifying further types of skin-friendly, biodegradable surfactants that may be employed for nanoemulsion production and exhibit similarly beneficial properties for dermal drug delivery. Among others, sucrose ester mixtures have been found interesting compounds for this task (Klang et al. 2011a; Calderilla-Fajardo et al. 2006; Cazares-Delgadillo et al. 2005).
In first studies, synthetic surfactants such as polysorbate 80 were found to be more effective permeation enhancers in comparative in vitro experiments than a hydrophilic sucrose laurate ester of comparable HLB value (Hoeller et al. 2009). This was ascribed to the enhancement mechanism of the different surfactants: while sucrose laurate interferes with the lipid chains and increases their fluidity, polysorbates may increase skin penetration both by interacting with intercellular lipid domains and keratin filaments, thus disturbing both the lipid matrix and the protein domain of the corneocyte layers (Nokhodchi et al. 2003). Later studies showed that sucrose stearate mixtures of similar HLB value as lecithin mixtures were equally suitable in terms of drug delivery from nanoemulsions and even superior in terms of physical stability (Klang et al. 2011a).
As already discussed, surfactants can be used to modify the surface charge of the droplets. Cationic surfactants such as stearylamine, oleylamine, chitosan or cetyltrimethylammonium bromide can be employed for this task. Apart from the amphiphilic phospholipids, nonionic surfactants such as poloxamers or polysorbates are frequently employed (Yang and Benita 2000). Polysorbate-type surfactants possess voluminous groups that provide for increased steric stabilisation. Likewise, surface-active polymers such as the cellulose ether hydroxypropyl methylcellulose (HPMC) can be employed to stabilise nanoemulsions as additional or even main surfactants (Schulz and Daniels 2000).
Importantly, the nature of the interfacial film surrounding the oil droplets may affect drug release. Mixtures of surfactants may lead to the formation of more compact interfacial films, which consequently form a more efficient barrier against drug release (Ibrahim et al. 2009). Interfacial films composed of lecithin alone do not represent a strong interfacial transport barrier, thus usually showing burst release properties. However, by creating mixed interfacial films by including further surfactants or nanoparticles, controlled release properties can be achieved for topical application. Recently, enhanced dermal accumulation of all-trans-retinol could be achieved by addition of oleylamine and silica nanoparticles to a conventional nanoemulsion, thus producing more complex interfacial films (Eskandar et al. 2009).
2.3.2 Role of Additional Compounds
Natural, semi-synthetic or synthetic lipids, fatty acids and oils can be employed for the production of oil-in-water nanoemulsions. For dermal application, skin-friendly cosmetic oils such as soybean oil, jojoba oil, castor oil, PCL liquid or squalene are popular choices. The presence of free fatty acids in the oil phase is beneficial for nanoemulsion stability, as reported for castor oil (Jumaa and Mueller 1998). In addition, the polarity of the oil phase affects the system’s stability against Ostwald ripening as well as drug release properties. Squalene not only acts as a ripening inhibitor due to its hydrophobic nature but also allows for the production of smaller droplet sizes in lecithin nanoemulsions than most other oils, which in turn may affect skin interaction and drug release (Fox 2009; Chung et al. 2001).
Variation of the amount of incorporated oil may affect physical system properties such as droplet size as well as drug release rates. Higher amounts of oil may lead to decreased drug release rates due to higher retention capacity (Hung et al. 2007). The microviscosity of the system may likewise be influenced by variations in the oil content. As a result, the wetting properties of nanoemulsions may be superior to those of conventional marketed products, thus exhibiting an increased therapeutic effect particularly in mucosal drug delivery (Ibrahim et al. 2009). In addition, viscosity-enhancing additives may increase the contact time between formulation and the skin. For this reason, nanoemulsions with or without addition of gelling agents may show improved penetration of incorporated drugs when compared to aqueous drug solutions or dispersions (Mou et al. 2008).
If required, penetration enhancers such as propylene glycol or oleic acid can be incorporated into nanoemulsions to further enhance skin penetration (Fang et al. 2004). Addition of cosurfactants such as polysorbates, sucrose esters or alkyl polyglucosides can serve the same purpose (Schwarz et al. 2012; Hoeller et al. 2009; Klang et al. 2010). Recent studies have shown that cyclodextrins, i.e. cyclic polysaccharide molecules, may likewise act as penetration enhancers for specific drugs when incorporated into nanoemulsions. This effect is most likely caused by improved solubilisation and increased availability of the drug at the skin surface and/or involvement of the cyclodextrins in oil droplet formation (Klang et al. 2010, 2011a).
3 Conclusion
In summary, the benefits of nanoemulsions for dermal application lie with their high skin friendliness and their excellent physical stability. The employed surfactants may serve to promote skin penetration of incorporated drugs. Enhanced in vivo efficacy of different drugs has been observed for nanoemulsion formulations due to their specific morphology and composition. Additional factors such as the droplet surface charge and viscosity of nanoemulsions can be modified with the help of different additives to further improve skin interaction and drug delivery. The possibility to incorporate various lipophilic as well as hydrophilic drugs by means of novel strategies renders nanoemulsions interesting vehicles for dermal and cosmetic applications.
References
Alves PM, Pohlmann AR, Guterres SS (2005) Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsion: development and rheological characterization. Pharmazie 60(12):900–904
Anton N, Vandamme TF (2011) Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm Res 28:978–985
Anton N, Gayet P, Benoit JP, Saulnier P (2007) Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion. Int J Pharm 344(1–2):44–52
Anton N, Mojzisova H, Porcher E, Benoit JP, Saulnier P (2010) Reverse micelle-loaded lipid nano-emulsions: new technology for nano-encapsulation of hydrophilic materials. Int J Pharm 398(1–2):204–209
Baker MT, Naguib M (2005) Propofol: the challenges of formulation. Anesthesiology 103(4):860–876
Baspinar Y, Borchert HH (2012) Penetration and release studies of positively and negatively charged nanoemulsions–is there a benefit of the positive charge? Int J Pharm 430(1–2):247–252
Benita S (1999) Prevention of topical and ocular oxidative stress by positively charged submicron emulsion. Biomed Pharmacother 53(4):193–206
Benita S, Levy MY (1993) Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization. J Pharm Sci 82(11):1069–1079
Calder PC, Jensen GL, Koletzko BV, Singer P, Wanten GJ (2010) Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med 36(5):735–749
Calderilla-Fajardo SB, Cazares-Delgadillo J, Villalobos-Garcia R, Quintanar-Guerrero D, Ganem-Quintanar A, Robles R (2006) Influence of sucrose esters on the in vivo percutaneous penetration of octyl methoxycinnamate formulated in nanocapsules, nanoemulsion, and emulsion. Drug Dev Ind Pharm 32(1):107–113
Cazares-Delgadillo J, Naik A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A (2005) Skin permeation enhancement by sucrose esters: a pH-dependent phenomenon. Int J Pharm 297(1–2):204–212
Cevc G, Vierl U (2010) Nanotechnology and the Transdermal route: a state of the art review and critical appraisal. J Control Release 141(3):277–299
Chiesa M, Garg J, Kang YT, Chen G (2008) Thermal conductivity and viscosity of water-in-oil nanoemulsions. Colloids Surf A Physicochem Eng Asp 326:67–72
Chung H, Kim TW, Kwon M, Kwon IC, Jeong SY (2001) Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system. J Control Release 71(3):339–350
Cortés-Muñoz M, Chevalier-Lucia D, Dumay E (2009) Characteristics of submicron emulsions prepared by ultra-high pressure homogenisation: Effect of chilled or frozen storage. Food Hydrocoll 23(3):640–654
Dirschka T, Radny P, Dominicus R, Mensing H, Bruning H, Jenne L et al (2012) Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol 166(1):137–146
Eskandar NG, Simovic S, Prestidge CA (2009) Nanoparticle coated submicron emulsions: sustained in-vitro release and improved dermal delivery of all-trans-retinol. Pharm Res 26(7):1764–1775
Fang JY, Leu YL, Chang CC, Lin CH, Tsai YH (2004) Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery. Drug Deliv 11(2):97–105
Fernandez P, André V, Rieger J, Kuehnle A (2004) Nano-emulsion formation by emulsion phase inversion. Colloids Surf A Physicochem Eng Asp 251:53–58
Fox CB (2009) Squalene emulsions for parenteral vaccine and drug delivery. Molecules 14(9):3286–3312
Friedman DI, Schwarz JS, Weisspapir M (1995) Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs. J Pharm Sci 84(3):324–329
Hoeller S, Sperger A, Valenta C (2009) Lecithin based nanoemulsions: a comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation. Int J Pharm 370(1–2):181–186
Hung CF, Fang CL, Liao MH, Fang JY (2007) The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion. Int J Pharm 335(1–2):193–202
Ibrahim SS, Awad GA, Geneidi A, Mortada ND (2009) Comparative effects of different cosurfactants on sterile prednisolone acetate ocular submicron emulsions stability and release. Colloids Surf B: Biointerfaces 69(2):225–231
Jumaa M, Mueller BW (1998) The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int J Pharm 163:81–89
Kirjavainen M, Monkkonen J, Saukkosaari M, Valjakka-Koskela R, Kiesvaara J, Urtti A (1999) Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Release 58(2):207–214
Klang V, Valenta C (2011) Lecithin-based nanoemulsions. J Drug Del Sci Tech 21(1):55–76
Klang SH, Parnas M, Benita S (1998) Emulsions as drug carriers – possibilities, limitations and future perspectives. In: Mueller RH, Benita S, Böhm BHL (eds) Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Medpharm Scientific Publishers, Stuttgart, pp 31–56
Klang V, Matsko N, Zimmermann AM, Vojnikovic E, Valenta C (2010) Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions. Int J Pharm 393(1–2):152–160
Klang V, Matsko N, Raupach K, El-Hagin N, Valenta C (2011a) Development of sucrose stearate-based nanoemulsions and optimisation through gamma-cyclodextrin. Eur J Pharm Biopharm 79:58–67
Klang V, Schwarz JC, Matsko N, Rezvani E, El-Hagin N, Wirth M et al (2011b) Semi-solid sucrose stearate-based emulsions as dermal drug delivery systems. Pharmaceutics 3:275–306
Klang V, Matsko NB, Valenta C, Hofer F (2012a) Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment. Micron 43:85–103
Klang V, Schwarz JC, Lenobel B, Nadj M, Auböck J, Wolzt M et al (2012b) In vitro vs in vivo tape stripping: validation of the porcine ear model and penetration assessment of novel sucrose stearate emulsions. Eur J Pharm Biopharm 80:604–614
Kotyla T, Kuo F, Moolchandani V, Wilson T, Nicolosi R (2008) Increased bioavailability of a transdermal application of a nano-sized emulsion preparation. Int J Pharm 347(1–2):144–148
Lademann J, Otberg N, Richter H, Weigmann HJ, Lindemann U, Schaefer H et al (2001) Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol 14(1):17–22
Maisch T, Santarelli F, Schreml S, Babilas P, Szeimies RM (2010) Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model. Exp Dermatol 19(8):e302–e305
Marxer EE, Brussler J, Becker A, Schummelfeder J, Schubert R, Nimsky C et al (2011) Development and characterization of new nanoscaled ultrasound active lipid dispersions as contrast agents. Eur J Pharm Biopharm 77(3):430–437
Mason TG, Wilking JN, Meleson K, Chang CB, Graves SM (2006) Nanoemulsions: formation, structure, and physical properties. J Phys Condens Matter 18:R635–R666
McClements DJ (2012) Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter 8:1719–1729
Mitri K, Shegokar R, Gohla S, Anselmi C, Mueller RH (2011) Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm 414(1–2):267–275
Mou D, Chen H, Du D, Mao C, Wan J, Xu H et al (2008) Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. Int J Pharm 353(1-2):270–6
Mueller RH (1996) Zetapotential und Partikelladung in der Laborpraxis. Band 37, Paperback APV ed. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH
Nokhodchi A, Shokri J, Dashbolaghi A, Hassan-Zadeh D, Ghafourian T, Barzegar-Jalali M (2003) The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm 250(2):359–369
Norden TP, Siekmann B, Lundquist S, Malmsten M (2001) Physicochemical characterisation of a drug-containing phospholipid-stabilised o/w emulsion for intravenous administration. Eur J Pharm Sci 13(4):393–401
Piemi MP, Korner D, Benita S, Marty J-P (1999) Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J Control Release 58(2):177–187
Porras M, Solans C, González C, Martinez A, Guinart A, Gutiérrez JM (2004) Studies of formation of W/O nano-emulsions. Colloids Surf A Physicochem Eng Asp 249(1–3):115–118
Puglia C, Rizza L, Drechsler M, Bonina F (2010) Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: characterization and in vitro and in vivo evaluation. Drug Deliv 17(3):123–129
Schulz MB, Daniels R (2000) Hydroxypropyl methylcellulose (HPMC) as emulsifier for submicron emulsions: influence of molecular weight and substitution type on the droplet size after high-pressure homogenization. Eur J Pharm Biopharm 49(3):231–236
Schwarz JC, Klang V, Karall S, Mahrhauser D, Resch GP, Valenta C (2012) Optimisation of multiple W/O/W nanoemulsions for dermal delivery of aciclovir. Int J Pharm 435(1):69–75
Sole I, Pey CM, Maestro A, Gonzalez C, Porras M, Solans C et al (2010) Nano-emulsions prepared by the phase inversion composition method: preparation variables and scale up. J Colloid Interface Sci 344(2):417–423
Sonneville-Aubrun O, Simonnet JT, L’Alloret F (2004) Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci 108–109:145–149
Spagnul A, Bouvier-Capely C, Phan G, Landon G, Tessier C, Suhard D et al (2011) Ex vivo decrease in uranium diffusion through intact and excoriated pig ear skin by a calixarene nanoemulsion. Eur J Pharm Biopharm 79(2):258–267
Tadros T, Izquierdo P, Esquena J, Solans C (2004) Formation and stability of nano-emulsions. Adv Colloid Interface Sci 108–109:303–318
Ullrich S, Metz H, Maeder K (2008) Sucrose ester nanodispersions: microviscosity and viscoelastic properties. Eur J Pharm Biopharm 70(2):550–555
van Nieuwenhuyzen W, Szuhaj BF (1998) Effects of lecithins and proteins on the stability of emulsions. Fett-Lipid 100(7):282–291
Wabel C (1998) Influence of lecithin on structure and stability of parenteral fat emulsions [Dissertation]. Friedrich-Alexander-Universität, Erlangen-Nürnberg
Yang SC, Benita S (2000) Enhanced absorption and drug targeting by positively charged submicron emulsions. Drug Dev Res 50(3–4):476–486
Yu C, Meng J, Chen J, Tang X (2009) Preparation of ergoloid mesylate submicron emulsions for enhancing nasal absorption and reducing nasal ciliotoxicity. Int J Pharm 375(1–2):16–21
Zhou H, Yue Y, Liu G, Li Y, Zhang J, Gong Q et al (2010) Preparation and characterization of a lecithin nanoemulsion as a topical delivery system. Nanoscale Res Lett 5:224–230
Acknowledgement
The authors would like to thank Dr. Tim Maisch and co-workers for providing Fig. 18.2.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Klang, V., Schwarz, J.C., Valenta, C. (2015). Nanoemulsions in Dermal Drug Delivery. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45013-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-662-45013-0_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45012-3
Online ISBN: 978-3-662-45013-0
eBook Packages: MedicineMedicine (R0)